Yearly Licence Tolerability and Immunogenicity Study of Fluval AB Seasonal Influenza Vaccine to be Used in the 2012/2013 Vaccination Season

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Influenza
Interventions
DRUG

Fluval AB vaccination

Vaccination with Fluval AB suspension for injection

Trial Locations (3)

H-1083

District Doctor's Office, Budapest

H-2085

District Doctor's Office, Pilisvörösvar

H-2000

District Doctor's Office, Szentendre

All Listed Sponsors
lead

Fluart Innovative Vaccine Ltd, Hungary

INDUSTRY